Sangrix CEO Jiang Buys 75,000 Class B Shares at $0.4390, Reaching ~35% Voting Power
SGRX is trading near its 52-week low of $0.385 (0.0% above the low) on light trading volume (0.1× avg).
Summary
Sangrix issued 75,000 Class B shares to Chairman/CEO Jinghai Jiang for $32,925 ($0.4390/share), giving him 100% of the Class B stock and about 35% of total voting power. No shareholder vote was required under the Nasdaq home-country exemption.
Key Events · Financing and Capital Events · SGRX
-
CEO Buys 75,000 Class B Shares
Under a Securities Purchase Agreement dated October 21, 2026, Jinghai Jiang — Chairman, CEO and COO — purchased 75,000 Class B Ordinary Shares at $0.4390 per share, for $32,925.00.
-
Voting Power Concentrates at ~35%
Following the issuance, Jiang holds 100% of the company's outstanding Class B ordinary shares, which represent approximately 35% of the total voting power of the issued and outstanding share capital.
-
No Shareholder Vote Required
Because the company relied on Nasdaq Listing Rule 5615(a)(3) home-country practice, Listing Rule 5635(d) shareholder approval does not apply to the issuance; the board and audit committee approved it.
-
Proceeds for Working Capital
Net proceeds are earmarked for general working capital and general corporate purposes. The shares were sold under Section 4(a)(2) and Regulation S exemptions and carry restrictive legends.
Analysis · SGRX · Crypto Assets
Why it matters: the chairman/CEO put $32,925 of new cash into the company by buying newly issued Class B stock at $0.4390 — above today's $0.3848 quote — so this is not an option exercise, and it comes with the stock at its 52-week low. Control is the bigger fact. Jiang now holds 100% of the Class B shares and roughly 35% of total voting power, and the company used the foreign-private-issuer home-country exemption to avoid a Nasdaq shareholder vote on the issuance. Minority holders therefore have materially less say over future decisions, and the capital raised is small relative to the company's needs. The move follows a September 18 20-F that disclosed a $14.3M FY2026 net loss and a material weakness in financial controls, along with a September 18 restatement of December 2025 interim financials.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 29.3% of the 1526 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SGRX was trading at $0.38 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $774.1K. The 52-week trading range was $0.38 to $126.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.